Norway Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Norway Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 72Price: Single User License – US$2500Norway Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Norway Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Norway Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Norway Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi , Novo Nordisk A/S , Eli Lilly andCompany , Medtronic, Inc., LifeScan, Inc.and others.
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Norway Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195383-norway-diabetes-care-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 41.2 List of Figures 52 Introduction 72.1 What is This Report About? 73 Diabetes Care Devices In Norway 83.1 Diabetes Care Devices, Norway, Overall Revenue ($m), USD Constant, 2004-2018 83.2 Diabetes Care Devices, Norway, Company Share (2010-2011) 134 Glucose Monitoring In Norway 154.1 Glucose Monitoring Overall Revenue, (2004-2018) 154.1.1 Blood Glucose Meters, Norway, Revenue (2004-2018) 194.2 Glucose Monitoring Overall Volume (2004-2018) 234.2.1 Blood Glucose Meters, Norway, Volume (2004-2018) 274.3 Glucose Monitoring Average Price (2004-2018) 304.4 Glucose Monitoring Distribution Share (2010-2011) 314.5 Glucose Monitoring, Norway, Company Share (2010-2011) 325 Insulin Delivery In Norway 345.1 Insulin Delivery Overall Revenue, (2004-2018) 345.1.1 Insulin Pens, Norway, Revenue (2004-2018) 385.1.2 Insulin Pumps, Norway, Revenue (2004-2018) 425.2 Insulin Delivery Overall Volume (2004-2018) 465.2.1 Insulin Pens, Norway, Volume (2004-2018) 505.2.2 Insulin Pumps, Norway, Volume (2004-2018) 545.3 Insulin Delivery Average Price (2004-2018) 575.4 Insulin Delivery Distribution Share (2010-2011) 58
5.5 Insulin Delivery, Norway, Company Share (2010-2011) 596 Overview of Key Companies in Norway Diabetes Care Devices Market 616.1 F. Hoffmann-La Roche Ltd. 616.1.1 Company Overview 616.2 Sanofi 616.2.1 Company Overview 616.3 Novo Nordisk A/S 626.3.1 Company Overview 626.4 Eli Lilly and Company 626.4.1 Company Overview 626.5 LifeScan, Inc. 626.5.1 Company Overview 626.6 Medtronic, Inc. 636.6.1 Company Overview 636.7 Becton, Dickinson and Company 636.7.1 Company Overview 636.8 Animas Corporation 636.8.1 Company Overview 636.9 Bayer HealthCare AG 646.9.1 Company Overview 646.10 Abbott Laboratories 646.10.1 Company Overview 646.11 Ypsomed Holding AG 646.11.1 Company Overview 646.12 Terumo Corporation 656.12.1 Company Overview 656.13 Nipro Corporation 656.13.1 Company Overview 657 Appendix 667.1 Global Markets Direct Research Methodology 667.2 Definitions of Markets Covered in the Report 677.2.1 Diabetes Care Devices 677.3 Secondary Research 707.4 Primary Research 707.5 Models 717.6 Forecasts 717.7 Expert Panel Validation 717.8 Currency Conversion 727.9 Contact Us 727.10 Disclaimer 721.1 List of Tables